Literature DB >> 18162610

Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification.

Marcel Liberman1, Estêvão Bassi, Marina Kamla Martinatti, Fábio Cerqueira Lario, João Wosniak, Pablo M A Pomerantzeff, Francisco R M Laurindo.   

Abstract

OBJECTIVE: We hypothesized that reactive oxygen species (ROS) contribute to progression of aortic valve (AV) calcification/stenosis. METHODS AND
RESULTS: We investigated ROS production and effects of antioxidants tempol and lipoic acid (LA) in calcification progression in rabbits given 0.5% cholesterol diet +10(4) IU/d Vit.D2 for 12 weeks. Superoxide and H2O2 microfluorotopography and 3-nitrotyrosine immunoreactivity showed increased signals not only in macrophages but preferentially around calcifying foci, in cells expressing osteoblast/osteoclast, but not macrophage markers. Such cells also showed increased expression of NAD(P)H oxidase subunits Nox2, p22phox, and protein disulfide isomerase. Nox4, but not Nox1 mRNA, was increased. Tempol augmented whereas LA decreased H2O2 signals. Importantly, AV calcification, assessed by echocardiography and histomorphometry, decreased 43% to 70% with LA, but increased with tempol (P < or = 0.05). Tempol further enhanced apoptosis and Nox4 expression. In human sclerotic or stenotic AV, we found analogous increases in ROS production and NAD(P)H oxidase expression around calcifying foci. An in vitro vascular smooth muscle cell (VSMC) calcification model also exhibited increased, catalase-inhibitable, calcium deposit with tempol, but not with LA.
CONCLUSIONS: Our data provide evidence that ROS, particularly hydrogen peroxide, potentiate AV calcification progression. However, tempol exhibited a paradoxical effect, exacerbating AV/vascular calcification, likely because of its induced increase in peroxide generation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162610     DOI: 10.1161/ATVBAHA.107.156745

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  80 in total

Review 1.  The Pathogenesis and treatment of the valvulopathy of aortic stenosis: Beyond the SEAS.

Authors:  Sammy Elmariah; Emile R Mohler
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

2.  Quiescin sulfhydryl oxidase (QSOX) is expressed in the human atheroma core: possible role in apoptosis.

Authors:  Claudia R de Andrade; Beatriz S Stolf; Victor Debbas; Daniela S Rosa; Jorge Kalil; Veronica Coelho; Francisco R M Laurindo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-11-09       Impact factor: 2.416

Review 3.  Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models.

Authors:  Robert M Weiss; Jordan D Miller; Donald D Heistad
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

Review 4.  The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification.

Authors:  Linda Demer; Yin Tintut
Journal:  Circ Res       Date:  2011-06-10       Impact factor: 17.367

5.  The effect of physiological stretch and the valvular endothelium on mitral valve proteomes.

Authors:  Mir S Ali; Xinmei Wang; Carla Mr Lacerda
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-05

6.  Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein O-GlcNAc Modification.

Authors:  Yabing Chen; Xinyang Zhao; Hui Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

Review 7.  Vascular calcification: pathophysiology and risk factors.

Authors:  Neal X Chen; Sharon M Moe
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

8.  Oxidative stress and nitric oxide pathway in adult patients who are candidates for cardiac surgery: patterns and differences.

Authors:  Viviana Cavalca; Elena Tremoli; Benedetta Porro; Fabrizio Veglia; Veronika Myasoedova; Isabella Squellerio; Daniela Manzone; Marco Zanobini; Matteo Trezzi; Matteo Nicola Dario Di Minno; José Pablo Werba; Calogero Tedesco; Francesco Alamanni; Alessandro Parolari
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-09-07

Review 9.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

10.  Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis.

Authors:  Emanuela Branchetti; Rachana Sainger; Paolo Poggio; Juan B Grau; Jeffrey Patterson-Fortin; Joseph E Bavaria; Michael Chorny; Eric Lai; Robert C Gorman; Robert J Levy; Giovanni Ferrari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.